The letter should outline the specific reason whether that's a documentation gap, a BMI threshold issue, a step therapy requirement, or a formulary exclusion
The researchers were focused on diabetes (not obesity) treatment, and I have not included their calculations of the cost of gaining approval for biosimilars
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
Our nutritional guidance will help combat weight loss with weight loss medications by creating healthy lifestyle changes that will result in better, more permanent results
population is estimated to be obese, and another 31 percent are overweight, the study noted
On the flip side, inadequate protein intake can increase the risk of falls and fractures, surgical complications, and reduced quality of life, among other adverse health outcomes